- Release Date: 18/12/23 09:02
- Summary: P2 trial shows significant improvements in Phelan-McDermid
- Price Sensitive: Yes
- Download Document 723.12KB
- Forums
- ASX - By Stock
- NEU
- Ann: P2 trial shows significant improvements in Phelan-McDermid
Ann: P2 trial shows significant improvements in Phelan-McDermid
-
- There are more pages in this discussion • 210 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.20 |
Change
0.220(1.10%) |
Mkt cap ! $2.570B |
Open | High | Low | Value | Volume |
$20.11 | $20.23 | $19.63 | $5.489M | 274.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 56 | $20.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.21 | 230 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 90 | 20.160 |
13 | 379 | 20.150 |
2 | 155 | 20.140 |
5 | 160 | 20.130 |
1 | 138 | 20.120 |
Price($) | Vol. | No. |
---|---|---|
20.170 | 121 | 4 |
20.180 | 533 | 7 |
20.190 | 930 | 5 |
20.200 | 2640 | 2 |
20.210 | 167 | 2 |
Last trade - 14.39pm 25/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |